ARCHIVES

SEC Investigating Bristol-Myers’ Sales Statements

This article is from The Cancer Letter archive.

Vol. 28 No. 28 | July 12, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: ACOS Moves Up Schedule for TNM Staging System From 1986 To “As Expeditiously As Possible”

January 13, 1984

In Brief: Eight Site Visits at Prospective Comprehensive Centers Scheduled For NCCAB Members In ’75, 76

July 4, 1975

AGS-003 Increased Survival In Combination with Sunitinib

February 24, 2012

Dingell Subcommittee Report Next Month To Include New Info

July 1, 1994

New NCI Shakeup: O’Connor Leave DCCP to return To International Office; Adamson Acting Director

September 12, 1980

FDA Grants Orphan Designation To Photofrin for Mesothelioma

December 30, 2011